Bristol-Myers Squibb Co. (bmy 5.1 02/22/31)
13F holders, Q2 2026 (June 30)1holders
$1.02avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Bristol-Myers Squibb Co. (bmy 5.1 02/22/31) in their 13F filings. The largest holder was Vermillion Wealth Management, Inc. ($10K).
- Company
- Bristol-Myers Squibb Co. (bmy 5.1 02/22/31)
- CUSIP
- 110122EG9
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $10K |
| Exits | 0 | $0 |
Ownership 1 holders
| Vermillion Wealth Management, Inc. | 0.00% | New | 10,000 | $10K |
"% of holder's portfolio" is BRISTOL-MYERS SQUIBB CO (BMY 5.1 02/22/31)'s weight in each manager's 13F, not the share of Bristol-Myers Squibb Co. (bmy 5.1 02/22/31) the manager owns.